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Summary
 
L1 is an immunoglobulin superfamily adhesion molecule highly expressed on neurons and in-
volved in cell motility, neurite outgrowth, axon fasciculation, myelination, and synaptic plas-
ticity. L1 is also expressed by nonneural cells, but its function outside of the nervous system has
not been studied extensively. We find that administration of an L1 monoclonal antibody in
vivo disrupts the normal remodeling of lymph node reticular matrix during an immune re-
sponse. Ultrastructural examination reveals that reticular fibroblasts in mice treated with L1
monoclonal antibodies fail to spread and envelop collagen fibers with their cellular processes.
The induced defect in the remodeling of the fibroblastic reticular system results in the loss of
normal nodal architecture, collapsed cortical sinusoids, and macrophage accumulation in mal-
formed sinuses. Surprisingly, such profound architectural abnormalities have no detectable ef-
fects on the primary immune response to protein antigens.
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L
 
ymph nodes (LNs) can undergo rapid and profound
hypertrophy during an immune response. However,
the mechanisms underlying lymphoid tissue matrix remod-
eling remain poorly understood. Previous studies of the
lymphoid reticular matrix in immune animals have largely
been descriptive in nature, as it has not been possible to
selectively disrupt this feature in an otherwise normal,
healthy animal.
Under normal immune conditions, the integrity of the
lymphoid tissue is maintained because of the adaptive na-
ture of the reticular matrix. This matrix, termed the fibro-
blastic reticular system (FRS),
 
1
 
 is comprised of a fibrous
reticulum and associated fibroblasts (1). The reticular fibers
are primarily made up of type III collagen, but also contain
small amounts of elastic fibers (2), microfibrils (3), type IV
collagen (4), and laminin (5). The elastic components, ad-
mixed with the collagen bundles, confer resiliency to the
fibers during organ distention.
Anchored to the reticular fibers are reticular fibroblasts
(RFs), which ensheathe the fibers by wrapping around
them in a manner analogous to Schwann cell enclosure of
axons (1, 6). The enclosure of the reticular fibers by RF cy-
toplasmic processes is sealed by desmosome-like junctional
complexes at the juxtaposed RFs’ membranes (7).
The reticular fibers and associated fibroblasts together
form a three-dimensional cellular reticulum that forms the
walls of sinuses and delimits compartments within the
node. Based on these structural features, the FRS is be-
lieved to function primarily as (
 
a
 
) a mechanical supportive
scaffolding, (
 
b
 
) a substratum for immune cell motility, and
(
 
c
 
) partitions that establish immune microenvironments. It
has also been hypothesized that the extracellular space
formed by the RF enclosure of the reticular fibers may fa-
cilitate antigen transport between different compartments
within the node (8–10).
Our studies of LN architecture began when, in the
course of studying the function of the L1 cell adhesion
molecule in the murine immune system, we observed
structural abnormalities in LNs from mice injected with an
L1 mAb. L1 is a type I transmembrane glycoprotein with
an apparent molecular mass of 200 kD that is highly ex-
pressed by neural cells and tumors of neural origin (11). Al-
though L1 was isolated and purified initially from mouse
 
1
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brain extracts, it is also expressed by a variety of nonneu-
ronal cells. Cells of hematopoietic origin express L1 (12), as
do epithelial cells of the intestine (13) and male urogenital
tract (14). Of special relevance to this study, L1 expression
has also been demonstrated in mouse fibroblast L cells by
Western blot analysis of membrane preparations (15).
In this report, we examine the in vivo consequences of
influencing the effect of L1 during an immune response in
mice, using a previously described blocking rat anti–mouse
L1 mAb designated 324 (11). We find that in vivo adminis-
tration of the 324 anti-L1 mAb during the evolution of an
immune response prevents normal remodeling of the retic-
ular matrix of the draining popliteal LN.
 
Materials and Methods
 
Animals and Immunizations.
 
In vivo experiments were con-
ducted using 8–10-wk-old female BALB/CByj mice according
to the following protocol. On day 0, 25 
 
m
 
g of KLH/CFA was in-
jected into the right footpad of each mouse. For all structural ex-
periments, 250 
 
m
 
g of antibody was injected intraperitoneally each
day during days 2–5. Other studies testing the role of L1 during
the early phases of in vivo lymphocyte sensitization involved in-
jection with 300 
 
m
 
g of antibodies on days 0–5 and killing on day
7. In these latter experiments, antibody injection on day 0 pre-
ceded KLH/CFA immunization by 3 h. Mice were killed either
on day 6 or day 7, and popliteal LNs were harvested. Animals
were cared for in accordance with The Institutional Animal Care
and Use Committee of Boston University School of Medicine.
 
mAb Preparation.
 
Normal rat immunoglobulin (NRIg) was
purified from normal rat serum (The Jackson Laboratory, Bar
Harbor, ME) by HPLC using a J.T. Baker ABx semipreparative
column (16). Likewise, the 324 and TIB 126 (American Type
Culture Collection, Rockville, MD) hybridomas were grown as
ascitic tumors in NCR/nude mice (Taconic Farms Inc., German-
town, NY), and mAbs were purified from ascites by HPLC.
 
Transmission Electron Microscopy.
 
For transmission electron mi-
croscopy (TEM) studies, whole LNs were fixed in Karnovsky’s 1/2
strength fixative at 4
 
8
 
C for 
 
.
 
1 d. Tissues were washed with 0.1 M
phosphate buffer, postfixed in 1% OsO
 
4
 
 in 0.1 M phosphate
buffer, stained with 2% uranyl acetate in 60% ethanol, and dehy-
drated through an ethanol gradient and embedded in Araldite
(E.F. Fullam Inc., Latham, NY). 0.055-
 
m
 
m sections were exam-
ined and photographed in an electron microscope (model 300;
Philips Electronics, Eindhoven, The Netherlands).
 
Immunohistochemistry and Immunofluorescence Microscopy.
 
For con-
focal microscopy and immunohistochemical studies, LNs were
embedded in OCT (Miles Inc., Elkhart, IN), snap frozen, cryo-
sectioned, and acetone fixed. L1 expression in LN sections was
detected using anti–mouse L1 hyperimmune rabbit serum, or
preimmune rabbit serum diluted 1:2,000 (Covance Research
Products Inc., Denver, PA). Rabbit anti–mouse laminin 1:100
was detected with biotin-conjugated goat anti–rabbit IgG diluted
1:100 (both from Sigma Chemical Co., St. Louis, MO) followed
by ABC-HRP (Vector Laboratories, Inc., Burlingame, CA).
Laminin staining was detected colorimetrically using 3,3
 
9
 
-diami-
nobenzidine (Sigma Chemical Co.). Macrophages were immu-
nostained with biotin-conjugated anti–MAC-1 mAb (5C6) at 1
 
m
 
g/ml.
 
Confocal Laser Scanning Microscopy.
 
Confocal laser scanning
microscopy (CLSM) was carried out on a CLSM microscope (Leica
Microsystems, Wetzlar, Germany) equipped with an argon ion
laser. The objective used was a 50
 
3
 
 long working distance water
immersion lens. Continuous series of 2 scans/
 
m
 
m were recom-
bined to produce three-dimensional reconstructions of the entire
thickness of the LN tissue. Anti–vimentin-Cy3 1:50 (V-9 clone;
Sigma Chemical Co.) was used to stain frozen sections cut 48 
 
m
 
m
thick, which had a post-acetone fixation thickness of 16 
 
m
 
m.
 
Secondary In Vitro Lymphoproliferation.
 
LNs from KLH/CFA-
immune mice treated with either anti-L1 or control antibodies
were harvested on day 7. Lymphocytes were collected and
washed twice in ice-cold HBSS, resuspended in complete media,
and plated (5 
 
3
 
 10
 
5
 
 cells/well) in flat-bottomed 96-well plates
(Corning Glass Works, Corning, NY) containing media alone or
with varying concentrations of soluble KLH (Calbiochem Corp.,
La Jolla, CA). Cells were cultured for 4 d, pulsed for 8 h with 1 
 
m
 
Ci
of [
 
3
 
H]thymidine per well, and harvested using a PHD cell har-
vester (Cambridge Technology, Inc., Cambridge, MA). Counts
were determined using a liquid scintillation counter (model 1414;
Wallac, Gaithersburg, MD).
 
ELISA.
 
Day 7 serum was tested for KLH-specific IgM and
IgG antibodies by ELISA. Flexible PVC microtiter plates (Costar
Corp., Cambridge, MA) were coated overnight at 4
 
8
 
C with 20
 
m
 
g/ml KLH, and blocked with 4% BSA for 1 h at room temper-
ature (RT). Between each step, plates were washed five times
with PBS/0.2% Tween 20 (PBS/T). 50 
 
m
 
l of serum, diluted 1:
100 in PBS/T, was incubated for 1 h at RT. Alkaline phos-
phatase–conjugated rabbit anti–mouse IgM and IgG gamma-spe-
cific antibodies (Sigma Chemical Co.) were diluted 1:1,000 in
PBS/T and incubated for 1 h at RT. Colorimetric development
of AP substrate (Sigma Chemical Co.) was read at 405 nm in a
plate reader (Bio-Tek Instruments, Inc., Winooski, VT).
 
Flow Cytometry and LN Cell Enumeration.
 
The total number
of cells in the draining LNs was quantified by trypan blue dye ex-
clusion with a hemocytometer. Lymphocyte subsets were quanti-
fied by flow cytometry (Coulter Profile; Coulter Corp., Miami,
FL) using the following biotin-conjugated rat anti–mouse mAbs:
ant-B220 (3A1/6.1 ATCC, TIB 146), anti-CD8 (ATCC, TIB
105), anti-CD4 (GK1.5), and anti-CD11b (5C6). FITC-avidin D
cell sorter grade was used at 600 ng/ml (Vector Laboratories,
Inc.). Each incubation (both the primary antibody and fluores-
cein-conjugated avidin) was for 45 min, at 4
 
8
 
C. Afterwards, cells
were washed, fixed in 2% paraformaldehyde/PBS, and stored at
4
 
8
 
C until assayed.
 
Results
 
Model of LN Hypertrophy.
 
To study the function of L1
in the immune system in vivo, we used a well-character-
ized immune response model in which subcutaneous injec-
tion of 25 
 
m
 
g of KLH emulsified in CFA to the hind foot-
pad of a mouse elicits a vigorous immune response. In the
preimmune animal, the draining popliteal LN is modest in
size, averaging 1.1 mm in diameter (Table 1). However, by
day 6 after immunization, the mean greatest-width diame-
ter increases to 4 mm (Table 1). Since LNs are roughly
spherical in shape, this change in dimension represents a
63-fold increase in organ volume (i.e., 4
 
3
 
–1.1
 
3
 
). Such ex-
treme and rapid increases in organ volume must necessarily
be accompanied by extensive matrix remodeling, regulated
through poorly characterized mechanisms.
To elucidate the role of L1 in immune responses, we 
1955
 
Di Sciullo et al.
 
first identified by immunofluorescent microscopy the LN
cell types that express high levels of L1. In both the preim-
mune and KLH/CFA-elicited immune LN, cellular com-
ponents of the FRS stain positively for L1 by indirect im-
munofluorescence. In particular, L1 immunostaining is
especially prominent on fibroblastic sinus lining cells (Fig. 1
 
A
 
). Although parenchymal lymphoid cells are reported to
express L1 (12), in situ staining (Fig. 1 
 
A
 
) reveals that their
level of expression is significantly lower than that of cells of
the FRS.
 
LN Matrix Abnormalities.
 
To study the effects of L1
mAb treatment on the cellular components of the FRS, we
identified RFs by immunofluorescent microscopy, staining
for the intermediate filament vimentin. Since fibroblasts
express high amounts of vimentin relative to lymphoid cells
(17), the cellular profile of RFs can be observed in situ. In
stacked two-dimensional images from CLSM (Fig. 2, 
 
A
 
and 
 
B
 
), RFs appear bright white against the dark red back-
ground. The normal staining pattern of RFs is that of an
intricately branching and elongated network of cellular
processes that course through the LN (Fig. 2 
 
A
 
). By con-
trast, RFs in 324 mAb–treated mice have a stubby, re-
tracted morphology (Fig. 2 
 
B
 
).
Under normal conditions, RFs modify the tissue matrix
by depositing extracellular matrix components as they
spread out and extend their cellular processes (5). Conse-
quently, laminin colocalizes with vimentin-positive reticu-
lar structures in both naive and immune LN sections (data
not shown). Therefore, we also examined reticular archi-
tecture by immunohistochemical staining for laminin. In
LNs from control mice, laminin is faintly detected along
long, branching reticular structures that thread through the
lymphoid parenchyma (Fig. 2 
 
C
 
). Control mice in these
experiments were injected with NRIg, a nonbinding nega-
tive control that yields a low background on indirect im-
munostaining. In contrast to the long, branching laminin
filaments of control mice, L1 mAb–treated mice have
short, fragmented, and stunted laminin filaments (Fig. 2 
 
D
 
).
This abbreviated discontinuous pattern of laminin staining
is strikingly similar to the appearance of the vimentin-
bright cells in Fig. 2 
 
B
 
. The greatest differences in RF mor-
phology, as identified by both vimentin and laminin im-
munostaining, were observed in the cortex and paracortex.
These regions of the LN bear the greatest degree of pack-
ing and distention due to lymphocyte influx and prolifera-
tion.
 
RF Ultrastructural Abnormalities.
 
To gain insight into the
fine histologic structure of the FRS abnormalities induced
by the L1 mAb, LNs were embedded in plastic and ana-
lyzed by light and TEM. Both NRIg (a nonbinding con-
trol) and anti-class I mAb (a binding negative control) were
used as control antibodies with identical results. When RFs
are viewed by TEM, they normally appear flattened, with
elongated slender processes and large ovoid nuclei with pe-
ripherally condensed chromatin (1, 18, 19). The striated
collagenous components of the reticular fibers are enclosed
within the RF’s cell processes. When the tissue is sectioned
in a single plane, the cytoplasm of RFs appears typically as a
double-contoured cellular profile with reticular fibers in
between. These characteristic features of normal RFs are
evident in an electron micrograph of a control group LN
(Fig. 3, 
 
A
 
 and 
 
B
 
). The RF envelops itself around reticular
fibers, providing anchorage to matrix components (1, 6)
and mechanical support for the RF cell body.
In contrast, these normal ultrastructural features of LN
architecture are largely absent in LNs from animals treated
with the L1 mAb (Fig. 3 
 
C
 
). In LNs from the L1 mAb–
treated group, there were few distinguishable sinusoids in
the cortex and paracortex. The few sinusoids that were
found were lined with malformed RFs that were short,
plump, and lacked the double-contour feature (Fig. 3 
 
C
 
).
The absence of the double-contour morphology indicates
the absence of cytoplasmic processes extending around re-
ticular fibers. Therefore, RFs were unable to spread out on
and attach to their substrate, resulting in a loss of adher-
ence.
In fact, numerous RFs with little or no associated collag-
enous components were apparently sloughed into collapsed
sinusoidal spaces (Fig. 4, 
 
A
 
 and 
 
B
 
). Fig. 4 
 
A
 
 (light photomi-
crograph) and 
 
B
 
 (electron photomicrograph) both show
abnormally shaped RFs. The cell identified as an RF in Fig.
4 
 
A
 
 appears to be tethered to the underlying matrix at the
extreme distal end of the cell process. The RF appears to
have only a single, unidirectional cytoplasmic process orig-
inating from an eccentrically located nucleus. A similarly
shaped RF, with an eccentrically located nucleus, is located
towards the left of center in Fig. 4 
 
B
 
. It is still attached to
the underlying matrix, despite a lack of cytoplasmic double
contour and unidirectional cytoplasmic extension. Two
other RFs, distinguishable by nuclear morphology, are lo-
cated towards the right in the photomicrograph, and are
free within the sinusoidal space, unattached to any underly-
ing extracellular matrix.
 
Collapsed Sinusoids and Loss of Nodular Architecture.
 
Normal
LN compartmentalization is characterized by well-formed
cortical sinusoids, as shown in the control group low
power photomicrograph (Fig. 2 
 
E
 
). The sinusoids delimit
the lymphoid parenchyma into distinct lymphoid nodules.
 
Table 1.
 
Greatest-width Diameter of LN Frozen Sections
 
Antibody Mean diameter
 
mm
 
Preimmune 1.1 
 
6
 
 0.04
Postimmune day 6
L1 mAb 4.0 
 
6
 
 0.31
NRIg 4.1 
 
6
 
 0.46
Greatest-width diameter of LN frozen sections from preimmune and
postimmune day 6 mice. Five LNs from each group were serially cut,
and the greatest-width diameter of each LN was recorded. Data repre-
sent the means 
 
6
 
 SE. At day 6 after immunization, no statistical differ-
ence existed between the L1 mAb–treated group compared with
NRIg-treated mice, as determined by analysis of variance (ANOVA). 
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During LN hypertrophy, the cell bodies of RFs extend
along the sinusoidal lining to maintain a fenestrated barrier
that partitions cells of the parenchyma from the sinusoidal
lumen (18, 19). The extension of RFs is necessary to main-
tain the continuity of the cortical sinusoids with the sub-
capsular sinus (
 
Scs
 
, Fig. 2 
 
E
 
). L1 mAb treatment impairs RF
cellular extension, preventing normal formation of cortical
sinusoids and a profound loss of parenchymal nodular com-
partmentalization (Fig. 2 
 
F
 
). In Fig. 2 
 
F
 
, the subcapsular si-
nus (
 
Scs
 
) just barely begins to invaginate from the capsule,
where it ends.
 
Macrophage Aggregation in Blind-ended Sinuses.
 
Under nor-
mal conditions, a labyrinth of sinusoids channel lymphatic
fluid and cells through the LN. Cells entering via the affer-
ent lymphatics percolate inwards, from the subcapsular si-
nus to the sinusoids. In this particular immune response
model, the majority of the cells trafficking into the LN
from the afferent lymphatics are macrophages (M
 
f
 
s) (20).
Normally, M
 
f
 
s do not form large aggregates, but are rela-
tively evenly distributed throughout the parafollicular and
medullary zones of the node. During normal immune re-
sponses, resident M
 
f
 
s are sometimes found adherent to the
sinusoidal wall and, in some cases, directly anchored to re-
ticular fibers (6). In Fig. 5 
 
A
 
, the distribution and appear-
ance of M
 
f
 
s in normal parafollicular sinusoids is shown in
an LN section from an NRIg-treated mouse.
In the L1 mAb–treated mice, the consequence of dis-
rupting the normal remodeling of cortical sinusoids is ab-
normal cellular traffic and accumulation of M
 
f
 
s at appar-
ently dead-end sinusoids. All LNs from L1 mAb–treated
mice were found to contain at least one large aggregate of
M
 
f
 
s (Fig. 5 
 
B
 
). Since the centrally located cells in the ag-
gregate are not adherent to underlying matrix, they often
fall out during tissue processing, creating the appearance of
a false lumen (
 
S
 
, Fig. 5 
 
B
 
). By immunohistochemical analy-
sis of serial sections for laminin (faintly present on sinusoi-
dal walls) and CD31 (present on endothelium), the cellular
aggregates were determined to be contained within sinuso-
ids, not blood vessels (data not shown).
 
Functional Immune Consequences of L1 mAb Treatment.
 
To assess the functional consequences of the architectural
abnormalities, we measured several independent indices of
immune function. We find that treatment with L1 mAbs
does not noticeably alter primary immune responses. The
battery of functional assays used are summarized in Table 2.
 
Normal Lymphocyte Blood Vascular Transmigration.
 
Despite
the effect of the L1 mAb treatment on the LN FRS, it did
not cause any detectable morphologic change in the blood
vasculature. Normal venules were identified on plastic-
embedded sections stained with toluidine blue (Fig. 2, 
 
E
 
 and
 
F
 
) and by immunohistochemistry for laminin (Fig. 2, 
 
C
 
and 
 
D
 
). Since postcapillary venules are major sites of lym-
phocyte transmigration into activated LNs, we assayed their
functional integrity by measuring the total number of lym-
phocytes within the LN. Moreover, we enumerated T and
B lymphocyte subsets. The total number of lymphocytes
and percentages of T and B lymphocyte subsets were not
changed with L1 mAb treatment (Table 3). Additionally,
the mean diameter of LNs from mice treated with the L1
mAb was not statistically different from the NRIg control
group (Table 1). These observations strongly suggest that
L1 is not essential for lymphocyte blood vascular transmi-
gration, at least in this experimental system.
In addition, the IgG and IgM antibody responses to in-
jected protein antigen (KLH) were not different in the L1
mAb–treated group compared with controls (Fig. 6 
 
A
 
).
Also, lymphocytes taken from the draining LNs of L1 mAb–
treated mice proliferated equally vigorously in response to
antigen
 
 
 
in vitro, compared with control mice (Fig. 6 
 
B
 
).
When L1 mAb treatment was tested repeatedly in an ad-
ditional in vivo immune assay (delayed type hypersensitivity
[DTH]), immune responses did not differ statistically from
control mice (Table 2). Likewise, soluble L1 mAb used at 20
 
m
 
g/ml does not affect a one-way MLR (Table 2).
 
Discussion
 
The data presented in this report provide the first in vivo
demonstration of a role for L1 in LN matrix reorganization
Figure 1. L1 expression by fibroblastic sinus lining cells. Immunofluo-
rescence micrographs of 16-mm-thick frozen LN sections stained with
anti–mouse L1 hyperimmune rabbit serum (A) or preimmune rabbit se-
rum (B). S, Sinusoid. Note intense L1 immunoreactivity of fibroblastic si-
nus lining cells (arrowheads) compared with the low level fluorescence of
lymphoid cells located in the parenchyma. B (negative control) is of a se-
rial section of the same LN, including a comparable sinusoid (S).1957 Di Sciullo et al.
during immune hypertrophy. L1 mAb administration dur-
ing the course of an immune response results in collapsed
sinusoids and loss of nodular compartmentalization in the
draining hypertrophied LN. At the cellular level, RFs were
short, plump, and often nonadherent to the underlying ma-
trix. The loss of normal architecture is the result of an in-
ability of the RF to elongate and envelop the reticular ma-
trix as the LN distends. Fibroblast cell elongation is a
Figure 2. Histological and immunological examination of FRS architecture in immune LNs. Controls A, C, and E were harvested from mice injected
with the NRIg. B, D, and F are LNs from L1 mAb–injected animals. (A and B) Stacked confocal images of LN sections cut 48 mm thick and immuno-
stained for vimentin. The RF processes stain brightest for vimentin and appear white against the dark red background. (C and D) Photomicrographs of
6-mm-thick frozen LN sections stained for laminin by immunohistochemistry. V, Venules. C, Capillaries. L, Laminin. (E and F) Photomicrographs of
toluidine blue–stained, 1-mm-thick, Araldite-embedded LN sections. E demonstrates normal compartmentalization of an NRIg-treated control LN. N,
Lymph nodule. V, Venule. S, Sinus. Scs, Subcapsular sinus. F illustrates the loss of nodular architecture and collapse of cortical sinuses in LNs from L1
mAb–treated animals. In F, the structure designated with a V is a venule, not a tangential cut of a sinusoid, as evidenced by the erythrocytes within its lu-
men (not easily visible at this low power). Identical results were obtained using both NRIg and anti-class I as control antibodies in experiments used for
plastic embedding. Bars, 10 mm in A–D, 20 mm in E and F.1958 L1 Is Important for Lymph Node Matrix Remodeling
necessary adaptive requirement during organ hypertrophy.
To our knowledge, these experiments represent the first
experimental system for the relatively selective disruption
of the LN FRS, and thus may serve as a useful model to
further study the function of the FRS.
L1 function is best characterized in the nervous system,
where it is involved in cell motility, neurite outgrowth, ax-
onal guidance and fasciculation, myelination, synaptic plas-
ticity, and memory formation (for a review, see references
21–23). L1 is also expressed by numerous nonneuronal cell
types, including epithelial cells (13, 14) and cells of he-
matopoietic origin (12). However, despite the wide ex-
pression of L1 by immune cells, there have been no pub-
lished in vivo studies of L1 function in the immune system.
Previous in vitro studies have demonstrated that L1 con-
tributes to Esb-MP lymphoma binding to bend3 endothe-
lioma cells (24), suggesting a role for L1 in lymphocyte
blood vascular transmigration. L1 also accounts, in part, for
the in vitro aggregation of activated splenic B lymphoblasts
(12). L1 expression by follicular dendritic cells in human
tonsils and by endothelial cell–associated arterioles in the
red pulp of normal human spleen further suggests an im-
portant function for L1 in the immune system (25).
The effect of the L1 mAb appears specific to RFs, pre-
venting RF elongation and attachment to the underlying
matrix. Specifically, the L1 mAb does not affect lympho-
cyte trafficking through the postcapillary venules or im-
mune function. Postcapillary venular function is assumed to
be intact because lymphocyte influx, as gauged by the total
cell number and subset quantification, is unchanged with
L1 mAb administration (Table 3). Antigen-specific serum
antibody and T lymphocyte sensitization are also unaffected
Figure 3. Transmission elec-
tron micrographs of LN cortical
sinuses. The normal flattened
and elongate morphology of an
RF (A, and inset B) are observed
in an LN from an NRIg-treated
control group mouse. The RF
that lines the sinusoid delimits
the parenchymal compartment
(P) from sinusoidal spaces (S). B
is a high magnification of the
area denoted with a box in A. In
B, note the double-contour ap-
pearance (opposing arrows) caused
by sectioning of the RF that has
ensheathed collagen fibers
(Coll). In contrast, RF from L1
mAb–treated mice (C) are
plump rather than flattened and
elongate, they lack the double-
contour morphology, and they
are not in close apposition to
collagen fibers. Bars, 10 mm in A
and C, 1 mm in B. The differ-
ence in mononuclear cell mor-
phology in the parenchyma of
L1 mAb–treated LNs compared
with the NRIg-treated controls
is not due to apoptosis (see Table
2). Similar results were obtained
in three separate experiments.1959 Di Sciullo et al.
by the L1 mAb (Fig. 6). These pertinent negative results
have been summarized in Table 2.
There are several compelling reasons suggesting that the
antibody is not directly or indirectly cytotoxic to RFs.
First, the antibody solution is not toxic when used at rela-
tively high concentrations (20 mg/ml) to either 3T3 fibro-
blasts or lymphocyte cultures grown for 4 d in vitro (Table
2). Second, anti-L1 mAb does not induce apoptosis of lym-
phocytes or accessory cells, as determined by in situ TUNEL
(terminal deoxynucleotidyl transferase–mediated dUTP nick
end labeling) analysis of LN sections. In addition, there is
no evidence suggesting that anti-L1 labels cells for anti-
body-dependent cell-mediated cytotoxicity or activates com-
plement. Specifically, follicular dendritic cells and interdigi-
tating dendritic cells are strongly L11 (reference 25, and our
unpublished observations). Despite the expression of L1,
repeated morphologic examination of these cell types (us-
ing the FDC-M1 and NLDC-145 mAbs, for follicular and
interdigitating dendritic cells, respectively) failed to identify
any demonstrable cytotoxic effects of anti-L1. Both cell num-
ber and dendritic arborization were unaffected by the anti-
L1 mAb (data not shown). In addition, L11 RFs in other
lymphoid organs not undergoing significant hypertrophy,
such as spleen, displayed no structural alteration. If nonspecific
cytotoxic mechanisms associated with antibody administra-
tion were the cause of the RF abnormality, the findings
should not have been so anatomically restricted. Finally, the
ultrastructural features do not suggest a cytotoxic mechanism
of action. Although sloughed RFs display certain ultra-
structural distinctions associated with detachment, they do
not display nuclear pyknosis or karyorrhexis, features associ-
ated with cell death. These data collectively argue against the
unlikely possibility that anti-L1 mAb selectively targets fibro-
blastic reticular cells for complement-mediated lysis or anti-
body-dependent cell-mediated cytotoxicity. Rather, the data
are consistent with the interpretation that viable RFs slough
from their matrix as a consequence of being unable to adapt
to a changing substrate, as the LN undergoes rapid hyper-
trophy.
Based on what is known about L1, we speculate that the
L1 mAb affects fibroblast function either (a) by inhibiting
ligand binding directly involved in mechanical adhesion, or
(b) by interfering with L1-dependent signal transduction, or
a combination of both. L1 ligands that present in the LN
microenvironment include laminin, L1 itself through ho-
motypic interactions on adjacent cells, or integrins, like
very late antigen-5 and the vitronectin receptor (avb3).
Therefore, the inability of L1 expressed by RFs to bind to
one or more of these ligands might directly result in an in-
ability to elongate.
The KLH/CFA immune response model we used is
characterized by an initial antigen–nonspecific, mononu-
clear inflammatory response at the site of subcutaneous in-
jection. Within the first 48 h after antigen injection, anti-
gen-bearing Mfs and Langerhans cells migrate to the
draining popliteal LN (20, 26). Our previous study on this
immune response model indicated that lymphocyte influx
is maximal during days 3–7 after antigenic challenge (27).
Since the focus of this paper is on LN remodeling, adminis-
tration of anti-L1 during this narrow time window allowed
for the development of a severe architectural abnormality
while simultaneously minimizing the amount of time dur-
ing which an anti–rat IgG host response could occur.
Therefore, this model enabled us to study events critical to
matrix remodeling during the period of time when the LN
enlarges 50 times its original volume.
The spleen also has fibroblastic reticular cells that express
L1 (our unpublished data), but its architecture remains un-
affected by anti-L1 antibody treatment. We believe this is
Figure 4. Sloughed RFs in sinuses of LNs from L1 mAb–treated mice.
(A) A light photomicrograph of a plastic-embedded LN stained with tolu-
idine blue. A malformed RF has largely detached from the sinus wall (cell
labeled RF), tethered by a cytoplasmic process that remains attached at its
end. (B) TEM image of three RFs, identifiable by a distinctive pattern of
peripheral chromatin condensation and a large, elongated nucleus. All
three RFs lack the cytoplasmic double-contour feature. The RF to the
left of center has a similar abnormal, unidirectional cytoplasmic process as
the RF in A. The two RFs in the right half of the field are not associated
with collagen fibers and appear sloughed into the lumen of the sinus. S,
Sinus. P, Parenchyma. Scs, Subcapsular sinus. Bars, 10 mm.1960 L1 Is Important for Lymph Node Matrix Remodeling
because the spleen does not undergo a comparable degree
of hypertrophy as the z50-fold enlargement of the drain-
ing LN. In fact, our data indicate that the L1 antibody acts
upon RFs only during organ remodeling. We speculate
that the antibody does not directly cause detachment, but
rather prevents RF reattachment to underlying matrix dur-
ing cellular extension.
In terms of the functional analysis of L1 on immune
cells, this battery of experiments can be viewed as the first
step in characterizing this previously overlooked molecule
in the immune system. We have intentionally limited our
functional studies to day 7 after immunization to avoid the
possibility of artifactual results associated with immune
complex formation (host anti–rat IgG—rat IgG complex).
In preliminary experiments, we noticed immune complex
deposition in the LN vasculature in mice injected for
longer time periods (2–3 wk). For this reason, we limited
our studies to the effects that could be observed within
only a few days after administration of the L1 mAb. Up to
the seventh day after immunization (5 d after L1 mAb ad-
ministration), no detectable anti–rat IgG was present in the
serum (data not shown). Using anti-L1 to disrupt the FRS
architecture in the KLH/CFA system, we infer that an in-
tact LN architecture is not necessary for the evolution of
Figure 5. Immunohistochem-
istry staining for macrophage
marker CD11b in frozen LN
sections. (A) Representative of
the normal distribution of Mfs
in the parafollicular area from an
NRIg-treated mouse. Note the
round follicle on the left. (B)
Mf aggregates (arrows) are
present in LNs from L1 mAb–
treated mice. S, Space formed
during histologic processing. The
Mf aggregates in B are contained
within malformed sinusoids.1961 Di Sciullo et al.
primary immune responses, since no detectable differences
were observed in IgM or isotype-switched IgG gamma
anti-KLH–specific antibody levels, or in the level of T
lymphocyte sensitization (Fig. 6).
Furthermore, since anti-L1 antibody treatment preceded
KLH/CFA immunization in some functional experiments
(see legend to Table 2, and Materials and Methods), it ap-
pears that the L1 molecule may not be essential to antigen
presentation and early lymphocyte activation in primary
immune responses.
The FRS adapts to organ distention both mechanically
and at the cellular level. At the mechanical level, stretching
of the reticular network is possible because LN ultrastruc-
ture is preformed before the onset of an immune response.
In a study of postnatal LN development in rats, Yoshida
and Takaya found that most of the gross histologic features
of LN architecture are apparent by postnatal day 5, includ-
ing the capsule, subcapsular sinuses, reticular fibers, and dis-
tinctive cortical and medullary zones. Furthermore, by
postnatal days 16–23, reticular fibers containing elastic
Table 2. Summary of Assays of Lymphocyte Function Using L1 mAb
Experiment Result Table
In vivo assays
LN organ size Normal Table 1
Total number of LN cells and subsets Normal Table 3
Antigen-specific primary antibody response Normal Fig. 6
T cell antigen–specific sensitization Normal Fig. 6
In situ TUNEL assay of apoptotic foci in LN sections Normal Not shown
DTH Normal Not shown
In vitro assays
Secondary in vitro lymphoproliferation Normal Not shown
One-way MLR Normal Not shown
NIH 3T3 proliferation with L1 mAb Normal Not shown
Experiments were conducted using the 324 anti-L1 mAb and control antibodies TIB 126 anti-class I, M174.4 anti–LFA-1, and NRIg. The dosage
of 250 mg/mouse/d from days 2–5 consistently caused disruption of the FRS in KLH/CFA protocol. Anti-L1 antibody was also injected on days 0–5 to
study potential effects of L1 in earlier immune events. This earlier administration of antibody was performed for the KLH/CFA and DTH experi-
ments. No observed alterations in T cell sensitization, serum titers, and effector phase inflammatory responses resulted from the earlier antibody ad-
ministration. In both the MLR experiments and NIH 3T3 cell proliferation assay, the 324 anti-L1 mAb and control antibodies were used at a con-
centration of 20 mg/ml. Proliferation was determined by [3H]thymidine uptake. TUNEL, Terminal deoxynucleotidyl transferase–mediated dUTP
nick end labeling.
Table 3. Total LN Cell Number and Lymphocyte Subsets
Antibody No. LN cells Mf CD4 B220 CD8
3 106 %%% %
Experiment 1 (n 5 3)
L1 33 6 12 44.0 6 3.2 14.7 6 3.8 13.9 6 3.2
Class I 32 6 3.2 46.1 6 2.4 17.0 6 2.2 13.9 6 3.3
Experiment 2 (n 5 4)
PBS 32 6 3.7 6.2 6 0.5 32.8 6 0.8
NRIg 28 6 3.5 6.1 6 0.4 33.8 6 1.8
L1 29 6 2.5 4.8 6 0.3 29.1 6 0.7
Class I 27 6 2.8 6.0 6 0.2 32.1 6 0.6
LFA-1 5 6 1.4* 9.8 6 0.5* 17.8 6 1.9*
Data represent the mean values 6 SE. In both experiments, there were no statistical differences between the L1 and negative control groups as deter-
mined by ANOVA. Those antibodies injected in vivo, comprising the different experimental groups, are TIB 126 (anti–class I MHC), 324 (anti-L1),
M17.4.4 (anti–LFA-1), and polyclonal NRIg. Mononuclear cell subsets were enumerated using the CD11b mAb 5C6, CD4 mAb GK1.5, 3A1/6.1
(B220), and CD8 mAb TIB 105. *Statistical significance P ,0.001 by ANOVA.1962 L1 Is Important for Lymph Node Matrix Remodeling
components were found to be ensheathed by RF cytoplas-
mic processes and sealed by junctional complexes (7).
Therefore, the organ’s blueprint is preestablished before
antigenic challenge. LN hypertrophy requires extensive
modification of these preset structures by the fibroblastic
reticular cells.
Sinus lining cells of LNs expressed moderate levels of L1,
higher than that of the surrounding parenchymal lympho-
cytes (Fig. 1). This is in contradistinction to the exception-
ally low level of L1 on most fibroblast cell lines, such as the
NIH 3T3 cell line. Previous investigators have traditionally
assumed that fibroblasts such as the 3T3 cell line express
nonphysiologic levels of L1 (28, 29). We are not the first to
demonstrate L1 expression by fibroblasts (15). However,
our data indicate for the first time that some fibroblastic cell
types can express higher levels of L1 in vivo.
The mechanisms by which RFs respond to the changing
environment during LN hypertrophy are unknown. One
possibility is that the mechanical strain on the reticular fi-
bers is sensed by the adherent fibroblasts through a mecha-
notransduction mechanism (30). Chemostimuli may also
contribute to the RF response, since the immune LN is
awash in cytokines, growth factors, and chemotactic fac-
tors. Scant data are presently available on the regulatory
mechanism(s) controlling remodeling of the extracellular
matrix by the FRS during immune responses.
We believe that this in vivo demonstration places L1
within the realm of interest to both cell biologists and im-
munologists. Until now, L1 has been considered primarily
a neural cell adhesion molecule, of primary interest to the
neurobiology community. If its function of cell extension is
more generalized to other cell types, such as fibroblasts,
then modulating L1 function with mAbs or genetic tech-
niques may provide a variety of new insights in unrelated
scientific areas. We speculate that the common denomina-
tor in understanding L1 function across these disparate
fields is the concept of cell extension. This hypothesis is
based on the observation that neurons, Schwann cells, den-
dritic cells of the LN, and RFs all possess the common
characteristics of having an elongated shape and expressing
relatively higher levels of L1. Moreover, L1 is functionally
important in facilitating neuronal extension in vitro and,
from this study, RF extension in vivo. Based on such anal-
ogies, we speculate that L1’s shared role is likely to be
found in the signaling, guidance, or maintenance of an
elongate cell shape.
Figure 6. Primary antibody response and ex
vivo lymphoproliferation to KLH/CFA. Injec-
tion of antibodies in this experiment was sched-
uled to precede immunization specifically to
test whether anti-L1 mAb treatment could in-
fluence early events in the immune response to
KLH/CFA. (A) Day 7, KLH-specific IgM and
IgG (gamma-specific) antibody responses. L1
mAb administration does not alter the KLH-
specific immune response, whereas LFA-1 mAb
significantly diminishes anti-KLH IgG titers (P
,0.001, ANOVA). (B) In vivo lymphocyte
sensitization is evaluated by in vitro antigen–
induced lymphoproliferation. LN cells from L1
mAb–treated mice proliferate equally well as controls. Proliferation of cells from anti–LFA-1–treated control mice is significantly less (P ,0.001, multi-
variate ANOVA). In this experiment, n 5 4 mice per group.
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